Accelerating Drug Discovery with  Neural Networks and Machine Learning

NeuroAI™ Advantage



At the core of NeuroAI™ is a multilayer neural network. Our artificial neurons mimic more accurately biological neurons. The neural network architecture used in most applications is based on an antiquated understanding of the way neurons in humans work. McCulloch and Pitts described such a nerve cell as a simple logic gate which receives multiple signals from dendrites and in case the accumulated signal exceeds a certain threshold, the neuron generates an output signal.

By implementing and incorporating latest discoveries in neuroscience, we continually enhance and build a more powerful neural network architecture. For example, there are as different populations of interneurons which depending on the circumstances will enhance or even inhibit signals of neurons. The advantage of this new architecture is that it can detect more accurately patterns in the complex multivariate data set of human behavior and cognition.